Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is that the $axsm trial?
Interesting dm as s1 agonist helps with agitation and $avxl drugs are showing similar traits
Oh i see
And i thought that greece patent expired in feb
silly me for believing co sponsored info
They prd the first 2-73 patent on notice of allowance on 08/12/15
i could not find another follow up after grant
Plus was a big deal and even if combo is not being pursued seems they would not hesitate to pr
im buying
Wow
There are no trials to compare outcome measures to at this point?
Just disease state data?
Is the n=25?
Exciting if it stays through 24 mo!
I was just saying its not really a material event until its assigned a #
Could be transferred to bp as part of a deal before finalizing
I think they have 90 days to pay the fees
What is the patent number he is supposed to be announcing?
Then there is no allowance yet right?
With the way the plus patent was delayed by a typo and simple citation of the don specific synergy its clear timing played a crucial role
15 mo data and some patients at 20 mo
divergance from don graphs could be trending wide
perhaps treatment ind in pd?
Is fartstain pivoting???
Got 5.76
Hoping patent cemented deal
still very quiet and no q cc
friday news
Is fine im using adaptive crossover not placebo arm
thanks
Is that why they say confirmed in the 2/9 and 5/18/15 prs?
The 5/18 says "was also confirmed "
But no mention of nih study
maybe some nd rule?
$avxl long @ 6.02
Buying ahead of news
Patent fees number des grant date and pr may be awaiting timing of other cats
Hey rocky watch me pull a rabbit out of my hat
not going to happen
The jig is up on this otp
$ntrp short @ 8
Did they have gottbetter and Silverman s involved?
Suits will be fighting over lp like little girls
shorting this down to the bottom
Possible securities fraud violations by the bod of ntrp?
Say it isnt so!
Ty for follow up links
Only have phone
T Maurice co inventor 2-73
3 pubs with Su
Dont think Su working with avxl compounds
Cant even sit on an sab without 100 ethics committee hoops
Su is mr sigma1 though
TP Su
irp.drugabuse.gov/Su.php
Thanks that post has all the correct info
14/395581 is not a monotherapy
i was reading 12/5222761
Which is listed there under 13/777471
Plus patent gives protection for lead compound in lead indication
game changer
Use you head
its hypothesis
dismiss it before bears use it as ammo
The fact its been there for over a year and someone just now queries it is stranger
$avxl $6
The epilepsy patent text is hypothetical
postulating on the correlation between murine and human subjects
The 2-73 p1 was done on healthy male volunteers between 18 & 55 yo
calm down folks
14/395581 was recently assigned to avxl
it is 2-73 monotherapy mou
15/194792 claims benefit but is not yet published
suppose this will be us 2-73 mono patent
Will it not be surprising to see synergy with don again in the presentations?
Just sayin
bios have to play the game
Go $avxl
$avxl long @ 5.75
J french all over aedd xiv
avxl in clinical session because 2-73 is in clinical study for ad
prolly same poster from dec 2015?
Wo2016064711 is not new
no national stage entries
A19-144 is 2-73 metabolite
patient data is theory
protection for 2-73 in ad is granted and whats most important
10-k from 1/13/09 lists the greek patents
Awesome resource
thank you very much
What does it matter?
I made mad money here but im gone and on to better things
gltu
What about it?
44 died right?
I say its 56 now
i like lane simions thesis and agree with his articles
the other ad co is on tbe right track
take the wedding ring off
Right on
your kind of a wacky poster
but then dish up the goods
takes a village
thank you!
They will reveal severe atrophy across the board
all 56 of them
you dont reverse severe cases by any statsig means
b analogues to work with homeostasis inducers
you will see
Yes for sure
Analogue dev will be needled to ahieve
full penetration
lol
The analogues could hold great promise in precision med
but without a b1 boost to funding $ntrp is ditw
back to the drawing board
Think if there was any signal in the seps they would have been parading that around
expecting good post data after that release is pure dreaming
Wait and buy the co that picks up the analogue ip cheap
Buying ahead of news
thanks to all the sage voices here!
Agitation aes with drug 3.5% vs 2.9% with placebo
not to good for an anti agitation indication
in russia they sold the drugs and it was all placebo
No they approve drugs for patients
and the uspto does not grant patients
they grant patents
Lmao
nice 2-73 is evergreened for mou
p3 coming!
Exactly
some here seem to think the missing sep data is going to come later
wake up it isnt coming because it s not statsig
Almost like they were actually trying for disease reversal in late stage patients
Yeah you're going to need a synthetic low dose chronic oral formulation right?
Got my 5.62
3854 long
patent issue is now enantiomer based
Nat stage will secure 2-73 monotherapy
plus is just quick boost
Lol ntrp will drop b1 and declare insightful focus on analogs
Precision med will be the path
hope to get efficacy alongside an upstream mixed receptor compound or something
20m mc by next raise
Told you it would be back at 50m
Only a matter of time before dewie cheatum & howe show up here
Plenty of settlement cash and a criminal rs to claim
Has there been any discussion here concerning wo2017013496?
They did pump in the pr saying former fda officer
could have left that for the byline
but do have to play your cards
capiak prob impressed too and left graciously
good to have the retrophin association gone
Is plus app investigator saying approx >16mg is out of scope of claim?
If so does that correlate with the stated 14mg
Patent game part of the entire puzzle